Literature DB >> 9270511

Biopsy specimen findings in patients with previous lower extremity cellulitis after saphenous venectomy for coronary artery bypass graft surgery.

L M Baddour1, P B Googe, S L Stevens.   

Abstract

BACKGROUND: No previous study has examined the immune and inflammatory mechanisms involved in the pathogenesis of lower extremity cellulitis after saphenous venectomy for coronary artery bypass graft surgery.
OBJECTIVE: Our purpose was to determine the histopathologic, immunologic, and inflammatory findings in skin biopsy specimens from saphenous venectomy limbs of patients with previous bouts of cellulitis.
METHODS: Biopsy specimens were obtained from five patients with previous episodes of cellulitis. Specimens of the contralateral lower extremity of each patient were obtained for controlled comparisons.
RESULTS: Histopathologic findings did not provide evidence that could account for the tendency for cellulitis to develop. Moreover, the distribution of CD1a, HLA-DR, intercellular adhesion molecule-1, and lymphocyte function-associated antigen type 1 were similar in specimens from the postvenectomy and contralateral legs. No tumor necrosis factor-alpha expression was found in specimens from the lower extremities.
CONCLUSION: The mechanisms responsible for the production of this disorder do not involve the mediators studied.

Entities:  

Mesh:

Year:  1997        PMID: 9270511     DOI: 10.1016/s0190-9622(97)80132-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Recent considerations in recurrent cellulitis.

Authors:  Larry M Baddour
Journal:  Curr Infect Dis Rep       Date:  2007-10       Impact factor: 3.725

Review 2.  [Erysipelas on postoperative scar in traumatology: report of a case and review of literature].

Authors:  Hatim Abid; Mohamed El Idrissi; Mohamed Shimi; Abdelhalim El Ibrahimi; Abdelmajid El Mrini; Nissrine Amraoui; Fatima Zohra Mernissi
Journal:  Pan Afr Med J       Date:  2015-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.